SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.

Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...

A new SARS-CoV-2 variant, Nimbus or NB.1.8.1, is drawing attention due to rising transmission in parts of Asia.

Long COVID also known as post-acute COVID-19 syndrome or PASC refers to the lingering symptoms and health complications that ...

CHENNAI: Dr. Danielle Beckman is a neuroscientist whose passion for studying the brain is helping to reveal how viral ...

The origins of COVID-19 remain a mystery as WHO says “Cannot rule out any theory” after an inconclusive study.

FDA vaccines chief Vinay Prasad limited broader use of COVID vaccines, citing reduced risk and data concerns. Read more here.

The 2023 to 2024 COVID-19 vaccine provided additional effectiveness against medically attended COVID-19, according to a study published online June 24 in JAMA Network Open. Ruth Link-Gelles, Ph.D., M.